PLOS BLOGS Book Corner
Blogger Tweets
sethmnookin: Agree 100%. “@PeteAbe: Maybe it'll work out. But hate that idea. He's finally swinging well, let him swing.”
EmilyAnthes: HA! (Also: Sad.) RT @Sci_Phile "Homeopaths Without Borders" should be called "Visitors Without Medicine" http://t.co/kXPg8M76hW
TravisSaunders: Full text of very cool new paper posted to the #SBRN website http://t.co/vsrF3kuDB2
hillaryrosner: @MattLuizza My pleasure. Like the use of the Twitter training. :)
stevesilberman: @publichistorian @TheClockSFMOMA It's *wonderful*.
daniel_lende: RT @aroepstorff: Jim Wilce, Semiotics of Authenticity at IMC, discusses the Finnish lament revival. Strong films of collective crying http:…
mfenner: @Stephen_Curry: "I sincerely hope the (San Francisco Declaration on Research Assessment) becomes landmark document" http://t.co/Mq2awm4fj2
MrEpid: @purdy_eve @HeatherM211 ... but I did get out...to the @avspacemuseum ... to see the #StarWars identities exhibit ... oh. #sadjedi
BethSkw: RT @susanorlean: I didn't write much this week but I worried a lot about writing. That counts, doesn't it?
Jason_Reads: Enjoy: angry amazon reviews of adorable dog costumes: http://t.co/Ayycpke1LP
jeancflanagan: Just watched “The Revisionaries” on Netflix - a look at the people behind the culture wars in the Texas Board of Education.
Blog Archives
This Week in PLOS Medicine: Socioeconomics of lung cancer; Vitamin D and obesity; PROGRESS
Category: General
Tagged chemotherapy, lung cancer, obesity, prognosis, socioeconomic status
Leave a comment
The Battle Over Generic Drugs in India (and elsewhere)
Category: cancer, drug patents, Ethics, generic drugs, Healthcare disparities
Tagged antiretroviral drugs, Cipla, CML, erlotinib, generic drugs, Gleevec, HIV/AIDS, imatinib, India, lung cancer, Novartis, patents, Roche, Tarceva, TRIPS
Leave a comment
Avastin for Lung Cancer
Category: cancer
Tagged Avastin, bevacizumab, Dana-Farber Cancer Institute, JAMA, lung cancer, non–small cell lung cancer, NSCLC
Leave a comment
